Vaccines for preventing rotavirus diarrhoea: vaccines in use-Reference-Cited by-同舟云学术

Vaccines for preventing rotavirus diarrhoea: vaccines in use

Published:2019-03-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Soares-Weiser Karla¹,Bergman Hanna²,Henschke Nicholas²,Pitan Femi³,Cunliffe Nigel⁴

Affiliation:

1. Cochrane; Editorial & Methods Department; St Albans House, 57 - 59 Haymarket London UK SW1Y 4QX

2. Cochrane; Cochrane Response; St Albans House 57-59 Haymarket London UK SW1Y 4QX

3. Chevron Corporation; 2 Chevron Drive Lekki Lagos Nigeria

4. University of Liverpool; Institute of Infection and Global Health, Faculty of Health and Life Sciences; Liverpool UK L69 7BE

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008521.pub4/epdf/full

Reference454 articles.

1. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007;Anh;Vaccine,2011

2. GlaxoSmithKline[109216-063] A phase II, randomized, double-blind, placebo-controlled study to evaluate the immunogenicity, reactogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) liquid vaccine, when given to healthy infants, in Philippines www.gsk-studyregister.com/study/3204

3. NCT00432380 Immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals' oral live attenuated human rotavirus (HRV) liquid vaccine (GSK 357941A) in healthy infants clinicaltrials.gov/show/NCT00432380

4. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007;Anh;Vaccine,2011

5. Anh DD Thiem VD Hutagalung Y Bock HL Suryakiran P Delem A Immunogenicity, reactogenicity and safety of the oral live attenuated human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) in Vietnamese Infants 13th International Congress on Infectious Diseases Abstracts, Poster Presentations

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combatting infectious diarrhea: innovations in treatment and vaccination strategies;Expert Review of Vaccines;2024-02-19

2. A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses;ACS Nano;2024-02-14

3. Rotavirus Infection and Genotyping in Yantai, Shandong Province, 2017–2019;Tropical Medicine and Infectious Disease;2023-02-03

4. Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China;Vaccine;2023-01

5. Maternal knowledge and attitudes towards rotavirus diarrhea and vaccine acceptance in Yogyakarta, Indonesia: a qualitative study;Paediatrica Indonesiana;2022-10-31